Difficulty: Medium
Average Score: 86%
Practice
Mustafa is a 60-year-old former smoker with severe COPD and cardiac disease associated with frequent episodes of bronchospasm. Which of the following is a bronchodilator useful in chronic obstructive pulmonary disease (COPD) and least likely to cause cardiac arrhythmia?
Correct answer
D
Rationale
In this scenario, the correct answer is option D: Ipratropium. Ipratropium is an anticholinergic bronchodilator that is useful in COPD treatment because it helps to relax the muscles around the airways, leading to bronchodilation and improved airflow. It is least likely to cause cardiac arrhythmias because it does not have significant systemic absorption that would lead to cardiovascular side effects.
A) Aminophylline is a bronchodilator that can be used in COPD; however, it has a narrow therapeutic window and is more likely to cause cardiac arrhythmias due to its potential for toxicity.
B) Cromolyn is a mast cell stabilizer and is not typically used as a bronchodilator in COPD. It is more commonly used for the prevention of asthma attacks triggered by exercise or exposure to allergens.
C) Epinephrine is a bronchodilator that can be used in acute bronchospasm, but it is not typically used as a long-term treatment for COPD due to its potential to increase heart rate and blood pressure, leading to cardiac arrhythmias in patients with underlying cardiac disease.
Educationally, it is crucial for healthcare providers to understand the mechanisms of action, indications, and side effect profiles of different respiratory medications to make appropriate treatment decisions for patients with respiratory conditions like COPD. Choosing the right medication based on the individual patient's condition and comorbidities is essential to optimize treatment outcomes and minimize adverse effects.
A) Aminophylline is a bronchodilator that can be used in COPD; however, it has a narrow therapeutic window and is more likely to cause cardiac arrhythmias due to its potential for toxicity.
B) Cromolyn is a mast cell stabilizer and is not typically used as a bronchodilator in COPD. It is more commonly used for the prevention of asthma attacks triggered by exercise or exposure to allergens.
C) Epinephrine is a bronchodilator that can be used in acute bronchospasm, but it is not typically used as a long-term treatment for COPD due to its potential to increase heart rate and blood pressure, leading to cardiac arrhythmias in patients with underlying cardiac disease.
Educationally, it is crucial for healthcare providers to understand the mechanisms of action, indications, and side effect profiles of different respiratory medications to make appropriate treatment decisions for patients with respiratory conditions like COPD. Choosing the right medication based on the individual patient's condition and comorbidities is essential to optimize treatment outcomes and minimize adverse effects.